acquired
Stage
About
Bonti was a biotechnology company; Alexey Konov served on its board and the company was acquired by Allergan for $285M in 2018.
Explore Bonti's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.